The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Read here for an analysis on Humacyte (HUMA) stock post-Symvess approval, potential upside in revenue generation, and ...

Plans for filing an IND was agreed with the FDA in a recent meeting –– Positive preclinical results of the small-diameter ATEV were recently ...

“We are excited to grow our pipeline by advancing the development of the BVP, an advanced tissue and organ system,” said Laura Niklason ... for use as a vascular conduit for extremity arterial ...